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1. INTRODUCTION 
Methylglyoxal bis(guanylhydrazone) (MGBG), 
an inhibitor of polyamine biosynthesis [l], is ap- 
parently transported into the interior of the cell (by 
virtue of its structural resemblance to spermidine) 
via an inducible transport system used by the natu- 
ral polyamines spermidine and spermine [2-51. 
Cellular uptake of polyamines, and hence also of 
MGBG, is strikingly enhanced under conditions of 
intracellular putrescine and spermidine depletion, 
as a result of the use of inhibitors of ornithine de- 
carboxylase (EC 4.1.1.17) [5]. Even though the lat- 
ter phenomenon is obviously aimed at normalizing 
the reduced intracellular polyamine pools, it also 
offers a means of enhancing the cellular accumula- 
tion of the antiproliferatively acting MGBG when 
profound growth inhibition is desired [6]. 
Although intracellular polyamine depletion trig- 
gers a variety of compensatory mechanisms, such 
as induction and stabilization of ornithine and ad- 
enosylmethionine (EC 4.1.150) decarboxylases (for 
ref. see [7]), the greatly enhanced transport of 
extracellular polyamines can apparently alone 
abolish the antiproliferative effects of polyamine 
antimetabolites (inhibitors of polyamine bio- 
synthesis) in the presence of only trace amounts of 
exogenous polyamines. This fact may be prac- 
tically important since polyamine antimetabolites 
[MGBG and 2-difluoromethylornithine (DFMO)] 
have already been used alone (for ref. see [6]) or in 
combination [8] in the treatment of human malig- 
nancies. 
We will show here that when cultured Ehrlich 
ascites carcinoma cells were exposed to MGBG for 
not longer than a few hours, the uptake of poly- 
amines, especially that of diamines, was greatly en- 
hanced. Exposure to MGBG likewise stimulated 
the uptake of polyamines by tumor cells that have 
been brought to the state of severe polyamine de- 
privation with DFMO, a condition characterized 
by strikingly increased uptake of polyamines (51. 
The enhanced uptake of polyamines induced by 
the antimetabolites was apparently responsible for 
the appearance of substantial amounts of cadaver- 
ine (and putrescine) in L1210 leukemia cells har- 
vested from mice treated with MGBG alone or in 
combination with DFMO. 
2. MATERIALS AND METHODS 
2.1. Cells 
Ehrlich ascites carcinoma cells were grown in 
RPM1 1640 medium supplemented with 5% 
pooled human serum (Finnish Red Cross Trans- 
fusion Service, Helsinki, Finland) and antibiotics. 
Murine L 12 10 cells were maintained exclusively in 
the peritoneal cavity of female DBA/2J Born mice. 
After harvesting the tumor cells were washed with 
physiological saline and disintegrated by ultra- 
sonication for MGBG determinations or sus- 
pended in 0.2 N perchloric acid for polyamine 
measurements. 
2.2. Chemicals 
MGBG was synthesized by and obtained from 
Orion Pharmaceutical Company (Helsinki, Fin- 
land). DFMO was a generous gift from the Centre 
de Recherche Merrell International (Strasbourg, 
France). [jH]putrescine (spec. act. 25.4 Ci/mmol), 
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[%]cadaverine (spec. act. 106.3 mCi/mmol), 
[3H]spermine (spec. act. 21.7 Ci/mmol) were pur- 
chased from the New England Nuclear Company 
(Dreieich, Federal Republic of Germany). 
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2.3. Analytical methods 
Polyamines were measured from perchloric-acid 
extracts by the method of Seiler [lo] with the mod- 
ifications introduced by Dreyfuss et al. [ll] using 
chloroform-n-butanol-dioxan (48: 1: 1, by vol.) as 
the solvent in the thin-layer chromatography of the 
dansylated amines. MGBG was determined by the 
method of Seppanen et al. [4] using adenosylmeth- 
ionine decarboxylase from baker’s yeast. Protein 
was measured by the method of Lowry et al. [12]. 
Cell densities were determined with the aid of an 
electronic particle counter (Coulter Electronics, 
Harpenden, England). 
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For the calculations of statistical differences, the 
two-tailed t-test was used. 1, 1 I I I I 
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3. RESULTS Time (h) 
An exposure of Ehrlich ascites carcinoma cells 
to MGBG for 6 h resulted in a distinct stimulation 
of polyamine uptake when measured after the 
transfer of the cells into drug-free medium (table 
1). As also shown in the table, after 2 h the uptake 
of putrescine and cadaverine was more effectively 
(about 4-fold) stimulated than that of spermidine 
and spermine (about 2.5-fold). From the amines 
tested, net uptake of putrescine appeared to be 
most rapid after pretreatment with MGBG (table 
1). Because of the unavailability of radiolabeled 
MGBG, we could not unambiguously show that a 
prior exposure to MGBG would also enhance its 
own uptake. The kinetics of MGBG uptake, in 
comparison with spermidine (see figs. 1 and 2) 
supported the idea of an autoinduction of the drug 
transport. 
Fig.1. Effect of a prior exposure to MGBG on the up- 
take of spermidine in polyamine-depleted Ehrlich as- 
cites cells. The cells were grown in the presence of 3 mM 
DFMO for 3 days whereafter 5 PM MGBG was added 
into the medium for various time periods (2 to 10 h). 
After MGBG treatment he cells were transferred into 
fresh medium containing 5 FM [3H]spermidine and 
polyamine uptake was measured at the times indicated. 
Treatment of tumor cells with DFMO rapidly 
results in a profound putrescine and spermidine 
deprivation, which in turn induces the polyamine 
transport system [5]. During severe polyamine de- 
pletion, all polyamines, including cadaverine, are 
taken up at a rate that is about lo-fold faster than 
in cells with normal intracellular polyamine pools 
15,131. 
vious treatment with DFMO, were exposed to 
MGBG for varying periods of time and the uptake 
of spermidine was then measured in drug-free 
medium. As shown in the figure, a prior treatment 
with MGBG, for any length of time, clearly en- 
hanced the uptake of spermidine by these poly- 
amine-depleted cells. Thus the loading with 
MGBG of tumor cells possessing reatly reduced 
intracellular putrescine and spermidine pools did 
not abolish the uptake of spermidine, on the con- 
trary, a further stimulation occurred. 
In the experiment depicted in fig.1, tumor cells 
depleted of putrescine and spermidine by a pre- 
When the experiment was performed in the re- 
verse order, i.e., the polyamine depleted cells were 
first loaded with spermidine (for 2 to 10 h) and the 
uptake of MGBG was measured thereafter (in the 
absence of spermidine), the situation (Iig.2) was 
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Table 1 
Effect of a prior exposure to MGBG on the uptake of polyamine in 
cultured Ehrlich ascites carcinoma cells 
August I982 
Duration of MGBG Polyamine uptake (pmol/ lo6 cells) 
the uptake exposure Put Cad SPd SPm 
2h _ 287 (1.0) 131 (1.0) 354 (1.0) 214 (1.0) 
2h + 1140 (4.0) 491 (3.8) 941 (2.7) 502 (2.4) 
6h _ 1150 (1.0) 471 (1.0) 1120 (1.0) 540 (1.0) 
6h + 2620 (2.3) 1170 (2.5) 1600 (1.4) 878 (1.6) 
Untreated cells and cells previously exposed to 5 PM MGBG for 6 h 
were transferred to fresh medium supplemented with 5 PM radio- 
labeled polyamines (0.05 $Wml). Polyamine uptake was measured 
at 2 h and 6 h after the medium change. Put, putrescine; Cad, 
cadaverine; Spd, spermidine; Spm, spermine 
just the opposite of that shown in fig.1. An incuba- lar polyamines (fig.2). It thus appears that MGBG, 
tion of the DFMO-treated cells for 2 h in the pres- though using the polyamine transport system, is 
ence of 5 PM spermidine was already sufficient to not recognized as a natural polyamine, at least as 
decrease the uptake of MGBG to low levels corres- regards the repression of the stimulated uptake 
ponding to that of cells with undepleted intracellu- system. 
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Fig.2. Effect of a prior exposure to spermidine on the 
uptake of MGBG in polyamine-depleted Ehrlich ascites 
cells. Experimental details as in tig.l, except that 
MGBG uptake was measured after loading the DFMO- 
treated cells with spermidine. 
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The practical consequences of the enhanced up- 
take induced by the antimetabolites of polyamines 
(DFMO, MGBG and their combination) in tumor- 
bearing animals are presented in table 2. In this 
experiment, L1210 tumor-bearing mice were treat- 
ed with DFMO (2% in drinking water) or MGBG 
(50 mg/kg every other day) or their combination 
and the polyamine contents of L1210 cells were 
measured after 5 days. As shown in table 2, the 
treatment with DFMO alone resulted in a virtually 
complete disappearance of putrescine and sperm- 
idine, while the spermine content significantly in- 
creased and low amounts of N-aminopropylcada- 
verine (the cadaverine-based analog of sperm- 
idine) were detectable. Administration of MGBG 
alone decreased the level of spermine, whereas the 
concentration of spermidine, and most notably 
that of putrescine, were elevated, and now readily 
measurable amounts of cadaverine appeared (ta- 
ble 2). The changes of tumor polyamine pattern 
were even more striking when these two polyamine 
antimetabolites were administered together. Pu- 
trescine remained at a high level and cadaverine 
now represented one of the major amines in the 
leukemia cells (table 2). The concentration of sper- 
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Table 2 
Effect of DFMO, MGBG and their combination on the polyamine content of 
L1210 cells in tumor-bearing mice 
Treatment Polyamines (nmol/mg protein f SD) 
Put Cad SPd *PC SPm 
None 1.05+0.16 n.d. 20.90 f 0.50 n.d. 12.24kO.62 
DFMO nd. n.d. 1.61k0.44b 1.3950.41 18.3422.91” 
MGBG 8.96 f 3.33a 2.87kO.86 25.9220.34b n.d. 7.94 + I .OOb 
DFMO + 5.35 + 1.50a 14.442 1.76 16.83 + 1.70a n.d. 7.68&0.75b 
MGBG 
ap <O.Ol 
bp <O.OOl 
The DBA/2J mice (4 animals in a group) were inoculated with 0.25 ml of L 12 10 
cell suspension and received DFMO (2% in drinking water), MGBG (50 mg/kg 
i.p. every 2 days) or the combination of the drugs until killed 5 days after the 
inoculation. Put, putrescine; Cad, cadaverine; Spd, spermidine; Apt, amino- 
propyl cadaverine; Spm, spermine; n.d., not detected 
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midine was more than 10 times higher in tumor 
cells collected from animals on the combined drug 
diet than that in cells obtained from animals re- 
ceiving DFMO alone. It is tempting to speculate 
that these changes, i.e., high levels of putrescine, 
cadaverine and spermidine resulted, at least partly, 
from an enhanced polyamine uptake from extra- 
cellular ascitic fluid (which always contains micro- 
molar concentrations of polyamines) rather than 
from endogenous synthesis that should have been 
blocked at two different sites. 
4. DISCUSSION 
The present findings may offer explanations for 
a variety of phenomena described in connection 
with the use of poiyamine antimetabolites. The en- 
hanced accumulation of putrescine in response to 
MGBG treatment is usually ascribed to a forward 
block of putrescine utilization (resulting from an 
inhibition of spermidine synthesis) together with a 
decrease in putrescine oxidation by diamine oxid- 
ase, since the latter enzyme is strongly inhibited by 
MGBG [ 141. However, the possibility remains that 
the increased uptake of this diamine (in the pre- 
sence of MGBG) has a major contribution to the 
enhanced accumulation. This view is supported by 
the fact that even in the presence of DFMO, an in- 
hibitor of omithine decarboxylase, putrescine con- 
tinued to accumulate at a distinctly enhanced rate 
(table 2). The accumulation of cadaverine, which 
in animal tissues is most probably synthesized 
through the action of omithine decarboxylase on 
lysine [ 15,161, likewise appears to result from an 
increased uptake from the extracellular compart- 
ment in the MGBG-treated animals. 
Thus both DFMO and MGBG enhanced the 
uptake of polyamines, most notably of diamines 
and the combined use of these compounds results 
in an additive effect (table 2). Prakash et al. [ 171 re- 
cently reported that anti-tumor effects exerted by 
DFMO on a murine sarcoma were largely reversed 
when l,l’-(methylethanediylidene)-dinitrilo bis(3- 
aminoguanidine) (MBAG, a close derivative of 
MGBG) was combined with DFMO. The latter 
compound was also reported to reverse DFMO-in- 
duced polyamine depletion in the tumor cells [ 171. 
Bartholeyns and Kock-Weser [ 181 described a sim- 
ilar antagonism between DFMO and MGBG 
using the same murine sarcoma model. It is difli- 
cult to imagine other mechanisms than an en- 
hanced uptake as being responsible for the nor- 
malization of intracellular polyamine pattern and 
the disappearance of the DFMO-induced tumor 
growth inhibition during the combined treatment. 
Not only can the natural polyamines (putrescine, 
185 
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spermidine and spermine) abolish the growth-in- 
hibitory effects of inhibitors of polyamine syn- 
thesis by enhanced uptake, but cadaverine and its 
aminopropyl derivatives have also to be taken into 
consideration. We recently found that replacement 
of putrescine and spermidine by cadaverine and 
aminopropylcadaverine is compatible with slow 
cell proliferation, at least in cultured Ehrlich as- 
cites carcinoma cells [ 191. Thus an accumulation of 
cadaverine from the extracellular space in re- 
sponse to DFMO and MGBG treatments is a pos- 
sible reason for the resumption of cell growth, 
even though the intracellular levels of the natural 
polyamines would be greatly lowered by the use of 
polyamine antimetabolites. 
A striking similarity between MGBG in animal 
cells and streptomycin in bacteria appears to exist. 
Holtje [20] recently reported that streptomycin in- 
duces a polyamine transport system in E. coli and 
utilizes the same system for its own transport. The 
author suggested, and also presented experimental 
evidence, that the binding of streptomycin to ribo- 
somes induces the polyamine transport system. By 
considering the structural resemblance between 
spermidine and MGBG and the finding that under 
polyamine depletion MGBG is preferentially ac- 
cumulated in the microsomal fraction of tumor 
cells [21], it may be justified to speculate that a 
similar mechanism for MGBG action is also oper- 
ating in animal cells. The fact that MGBG is able 
to induce the polyamine transport system (that is 
also utilized by the drug itself) but, unlike sper- 
midine, does not repress the stimulated uptake 
even at high intracellular concentration, would 
conceivably explain the ‘suicide type’ accumula- 
tion of the drug until cell death [22]. 
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